Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade in Tandem Autotransplantation for Multiple Myeloma
NCT01548573Phase 2Terminated
- Sponsor
- University of Iowa
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), POEMS syndrome (POEMS), amyloidosis, sponsored by University of Iowa. Started May 2012; status: terminated.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)POEMS syndrome (POEMS)amyloidosis
Beyond the preview
Go deeper on NCT01548573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01548573.